Serigne Lo

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Tuba N. Gide, Camelia Quek, Alexander M. Menzies et al. · Cancer Cell · 2019 · 1K citations · Full text

Life Sciences, Immunology, Oncology +17

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V. Long, Victoria Atkinson, Serigne Lo et al. · The Lancet Oncology · 2018 · 996 citations

Medicine, Immunology, Oncology +13

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie, Joshua D. Cohen, Kamel Lahouel et al. · New England Journal of Medicine · 2022 · 976 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Alexander M. Menzies, Rodabe N. Amaria, Elisa A. Rozeman et al. · Nature Medicine · 2021 · 430 citations

Medicine, Clinical Sciences, Oncology +15

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

Felicity Newell, Yan Kong, James S. Wilmott et al. · Nature Communications · 2019 · 340 citations · Full text

Medicine, Genetics, Oncology +17